Efficiency of cytoplasmic delivery by pH-sensitive liposomes to cells in culture
- PMID: 2172955
- DOI: 10.1023/a:1015908831507
Efficiency of cytoplasmic delivery by pH-sensitive liposomes to cells in culture
Abstract
The intracellular processing of pH-sensitive liposomes composed of cholesterylhemisuccinate (CHEMS) and dioleoylphosphatidylethanolamine (DOPE) by eukaryotic cell lines has been compared to non-pH-sensitive liposomes made of CHEMS and dioleoylphosphatidylcholine (DOPC). The pH-sensitive liposomes can deliver encapsulated fluorescent molecules [calcein, fluoresceinated dextran, fluoresceinated polypeptide, and diphtheria toxin A chain (DTA)] into the cytoplasm. Cytoplasmic delivery can be blocked in the presence of ammonium chloride or EDTA, indicating that the process requires a low-pH environment and the presence of divalent cations. Inhibition of cellular protein synthesis by DTA delivery from the pH-sensitive liposome is orders of magnitude greater than from the non-pH-sensitive liposome composition. The delivery of DTA into the cytoplasm by pH-sensitive liposomes is at least 0.01% of cell-associated liposomal DTA. There is no significant difference in the degradation rate of bovine serum albumin (BSA) or the rate of acidification of pH-sensitive dye, 8-hydroxy-1,3,6-pyrene-trisulfonate (HPTS), when delivered to cells in pH-sensitive and non-pH-sensitive liposomes. Thus the efficiency of cytoplasmic delivery is less than 10% of the cell-associated liposome contents, which is the smallest difference that can be detected by these two assays. Based upon the various assays used to measure liposome content disposition in the cell, we conclude that the efficiency of cytoplasmic delivery by the CHEMS/DOPE liposomes is greater than 0.01% and less than 10% of the cell-associated liposomal contents.
Similar articles
-
Endocytosis of liposomes by macrophages: binding, acidification and leakage of liposomes monitored by a new fluorescence assay.Biochim Biophys Acta. 1990 May 24;1024(2):352-66. doi: 10.1016/0005-2736(90)90365-u. Biochim Biophys Acta. 1990. PMID: 2162207
-
A novel pH-sensitive liposome formulation containing oleyl alcohol.Biochim Biophys Acta. 2002 Aug 19;1564(1):31-7. doi: 10.1016/s0005-2736(02)00399-1. Biochim Biophys Acta. 2002. PMID: 12100993
-
On the mechanisms of internalization and intracellular delivery mediated by pH-sensitive liposomes.Biochim Biophys Acta. 2001 Nov 1;1515(1):23-37. doi: 10.1016/s0005-2736(01)00389-3. Biochim Biophys Acta. 2001. PMID: 11597349
-
"Smart" delivery of antisense oligonucleotides by anionic pH-sensitive liposomes.Adv Drug Deliv Rev. 2004 Apr 23;56(7):931-46. doi: 10.1016/j.addr.2003.10.037. Adv Drug Deliv Rev. 2004. PMID: 15066753 Review.
-
pH-sensitive liposomes for drug delivery in cancer treatment.Ther Deliv. 2013 Sep;4(9):1099-123. doi: 10.4155/tde.13.80. Ther Deliv. 2013. PMID: 24024511 Review.
Cited by
-
Cytoplasmic delivery of liposomes into MCF-7 breast cancer cells mediated by cell-specific phage fusion coat protein.Mol Pharm. 2010 Aug 2;7(4):1149-58. doi: 10.1021/mp1000229. Mol Pharm. 2010. PMID: 20438086 Free PMC article.
-
Delivery of gene editing therapeutics.Nanomedicine. 2023 Nov;54:102711. doi: 10.1016/j.nano.2023.102711. Epub 2023 Oct 7. Nanomedicine. 2023. PMID: 37813236 Free PMC article. Review.
-
Cellular delivery of oligonucleotides by synthetic import peptide carrier.Pharm Res. 1997 Dec;14(12):1759-64. doi: 10.1023/a:1012188014919. Pharm Res. 1997. PMID: 9453065
-
Lipid-Based Drug Delivery Systems in Cancer Therapy: What Is Available and What Is Yet to Come.Pharmacol Rev. 2016 Jul;68(3):701-87. doi: 10.1124/pr.115.012070. Pharmacol Rev. 2016. PMID: 27363439 Free PMC article. Review.
-
Engineered nanomaterial uptake and tissue distribution: from cell to organism.Int J Nanomedicine. 2013;8:3255-69. doi: 10.2147/IJN.S49770. Epub 2013 Aug 27. Int J Nanomedicine. 2013. PMID: 24023514 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources